Washington Trust Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-134
| Closed | -$26K | – | 650 |
|
|
2024
Q3 | $26K | Sell |
134
-17
| -11% | -$3.3K | ﹤0.01% | 392 |
|
|
2024
Q2 | $35K | Buy |
151
+57
| +61% | +$13.2K | ﹤0.01% | 351 |
|
|
2024
Q1 | $20.3K | Buy |
94
+8
| +9% | +$1.73K | ﹤0.01% | 399 |
|
|
2023
Q4 | $22.3K | Hold |
86
| – | – | ﹤0.01% | 387 |
|
|
2023
Q3 | $22.1K | Hold |
86
| – | – | ﹤0.01% | 383 |
|
|
2023
Q2 | $24.5K | Sell |
86
-110
| -56% | -$31.3K | ﹤0.01% | 364 |
|
|
2023
Q1 | $54.5K | Sell |
196
-6
| -3% | -$1.67K | 0.01% | 299 |
|
|
2022
Q4 | $55.9K | Sell |
202
-399
| -66% | -$110K | 0.01% | 299 |
|
|
2022
Q3 | $160K | Sell |
601
-51
| -8% | -$13.6K | 0.02% | 219 |
|
|
2022
Q2 | $133K | Sell |
652
-343
| -34% | -$70K | 0.01% | 254 |
|
|
2022
Q1 | $210K | Sell |
995
-156
| -14% | -$32.9K | 0.01% | 229 |
|
|
2021
Q4 | $276K | Buy |
+1,151
| New | +$276K | 0.02% | 215 |
|